Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1717026

registered interest
date	09/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy: Expenditure
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what was the total amount spent by the NHS on radiotherapy services in England in the past year, broken down by (1) region, and (2) NHS trust.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4532
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>Whilst data for the past year is not yet available, the latest published data on radiotherapy costs is from the National Health Service national cost collection for 2021/22, where spend is reported as £550 million. More detailed data by the NHS trusts is also available at the NHS website, in an online only format.</p> answering member printed Lord Markham question first answered 20/05/2024 15:05:30 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1195986

registered interest
date	14/05/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have to ensure that diagnosed diabetics in the UK will have sufficient medication to prevent diabetic ketoacidosis, in the event that the UK leaves the transition period without a trade agreement with the EU on 31 December.
tabling member printed	Lord Roberts of Llandudno
uin	HL4532
answer	answer is ministerial correction date of answer 20/05/2020 answer text <p>As part of our concerted national efforts, we will continue doing everything we can to ensure patients continue to access safe and effective medicines in all scenarios.</p><p>It remains the Government’s objective to negotiate a future relationship with the European Union before the end of the Transition Period and to make sure that patients reap the rewards. Both the United Kingdom and EU, in their published negotiating documents, have stated objectives to reach an agreement on trade in goods. The UK’s published approach sets out how we want to facilitate trade in medicinal products such as diabetic medicines and medical radioisotopes and support high levels of patient safety.</p><p>The Department will continue to work closely with the pharmaceutical industry, the National Health Service and others in the supply chain to help ensure patients can access the medicines they need, and precautions are in place to reduce the likelihood of future shortages.</p> answering member printed Lord Bethell grouped question UIN HL4533 HL4534 question first answered 20/05/2020 15:56:08 answering member 4708 label Biography information for Lord Bethell
tabling member	3691 label Biography information for Lord Roberts of Llandudno